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Natural products have long been providing important drug leads for infectious diseases. Leishmaniasis is a 
protozoan parasitic disease found mainly in developing countries, and it has toxic therapies with few alternatives. 
Fungal infections have been the main cause of death in immunocompromised patients and new drugs are urgently 
needed. In this work, a total of 16 plant species belonging to 11 families, selected on an ethnopharmacological ba-
sis, were analyzed in vitro against Leishmania (L.) chagasi, Leishmania (L.) amazonensis, Candida krusei, and C. 
parapsilosis. Of these plant species, seven showed antifungal activity against C. krusei, five showed antileishmanial 
activity against L. chagasi and four against L. amazonensis, among them species of genus Plectranthus. Our find-
ings confirm the traditional therapeutic use of these plants in the treatment of infectious and inflammatory disorders 
and also offer insights into the isolation of active and novel drug prototypes, especially those used against neglected 
diseases as Leishmaniasis.
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Medicinal plants have been the basis for the treatment 
of various diseases in traditional methods. In Brazil, 
populations in rural areas rely on traditional medicines 
for the treatment of many infectious diseases. Some spe-
cies are included in prescriptions for therapeutic pur-
poses like the healing of wounds, inflammation due to 
microbial or parasitic infections, skin lesions, and ulcers 
(Lorenzi & Matos 2002). In some cases, the plant may be 
used for different purposes. For instance, the species of 
genus Plectranthus is traditionally used to treat a range 
of ailments including digestion, skin, infection, and re-
spiratory problems (Lukhoba et al. 2006). 
The Brazilian Atlantic forest (BAF) is one of the ma-
jor biodiverse areas of the world, providing therapeutics 
for ancient diseases (Tempone et al. 2005). Plants used in 
folk medicine have offered natural products for the treat-
ment of diseases caused by protozoan parasites. The dis-
covery of artemisinin, a sesquiterpene lactone produced 
by Artemisia annua, as a pharmaceutical for the treat-
ment of malaria promoted an interest in the discovery of 
new compounds from plants with antiprotozoal activity, 
especially those to treat against Leishmania parasites 
(Chan-Bacab & Peña-Rodrigues 2001). Leishmaniasis is 
a protozoan tropical disease that can manifest as a single 
cutaneous ulceration or can become a progressive and 
fatal disease (Singh & Sivakumar 2004). Besides the 
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limited and toxic chemotherapeutic arsenal that is com-
posed mainly of the pentavalent antimonials, amphoteri-
cin B (AmB) and pentamidine (PMD), the relapses due 
to resistant parasites demonstrate the urgent need for 
new drug candidates (Balaña-Fouce et al. 1998).
In recent decades, an increased incidence of fun-
gal infections has been observed as a consequence of 
the growing number of immunocompromised patients, 
particularly those with AIDS or those taking anticancer 
drugs (Rahalinson et al. 1994). The expanding pool of 
high-risk patients susceptible to the opportunistic patho-
gen indicated that the yeast genus Candida is the most 
important invasive agent (Sobel 2006). Amb represents 
the main therapy for systemic fungal infections, but its 
use is highly limited as a result of renal toxicity and sev-
eral other adverse effects (Zachino 2001). In some cases, 
azole-drugs, particularly fluconazole (FCZ), represent 
a less toxic alternative therapy agent although azole-
resistant strains have been reported. Brazilian flora has 
been an astonishing source of biologically active com-
pounds. Amazon forest plants have been showing prom-
ising results against Candida spp. (Carneiro et al. 2008). 
In this work, we have evaluated the antileishmanial and 
antifungal activities of 16 methanolic plant extracts from 
the BAF. Plants were selected from those that have tra-
ditional uses against cutaneous and infectious diseases 
such as ulcers, leishmaniasis, skin lesions, diarrhea, ma-
laria, and inflammations, and those that have antimicro-
bial properties.
MATERIALS AND METHODS
Plant material - The plants were collected at Insti-
tuto Plantarum de Estudos da Flora, Brazil, in 2006. 
The vouchers of the species studied are deposited in the 
Herbarium Plantarum (HPL) and include the following: 
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Plectranthus amboinicus (Lour.) Spreng. (voucher: H 
Lorenzi 3.411), Aristolochia cymbifera Mart. & Zucc. 
(voucher: H Lorenzi 2.115), Plectranthus barbatus An-
drews (voucher: H Lorenzi 771), Lippia alba (Mill.) N.E. 
Br (voucher: H Lorenzi 1.713), Hydrocotyle bonarien-
sis Lam. (voucher: H Lorenzi 3.516), Plectranthus neo-
chilus Schlechter (voucher: H Lorenzi 1.441), Justicia 
pectoralis var. stenophylla Leon. (voucher: H Lorenzi 
1.702), Herreria salsaparilha Mart. (voucher: H Lorenzi 
3.391), Mentha X piperita L. (voucher: H Lorenzi 1.364), 
Eleutherine bulbosa (Mill.) Urb. (voucher: H Lorenzi 
778), Baccharis trimera (Less.) DC. (voucher: H Lorenzi 
432), Calamintha adscendens Willk. & Lang. (voucher: 
H Lorenzi 1701), Albizia inundata (Mart.) Barneby & 
J.W. Grimes (voucher: H Lorenzi 1692), Bauhinia for-
ficata Link. (voucher: A Amaral Jr. 390), Cymbopogon 
citratus (DC.) Stapf. (voucher: H Lorenzi 3.462), and 
Plectranthus grandis (Cramer) R.H. Willemse (voucher: 
H Lorenzi 3.465).
Extract preparation - The dried (air incubator 55°C) 
and powered leaves (100 g) from plants were extracted 
with methanol (3 x 200 ml) through a maceration pro-
cess for 48 h/ 25°C. The crude extracts were obtained 
after evaporation under reduced pressure at 45oC in a 
rotating evaporator. All extracts were kept at 4°C until 
used in biological assays.
Parasites- Leishmania (L.) chagasi (strain MHOM/
BR/1972/LD) promastigotes were maintained in M-199 
medium supplemented with 10% calf serum and 2% 
human male urine (Singh et al. 2000) at 24°C. L. ama-
zonensis (strain PH8) was maintained in RPMI-1640 
medium, supplemented with 20% calf serum at 24°C.
Determination of the 50% effective concentration 
(EC50) - Promastigotes were used for all experiments, 
and the stationary phase was reached at 2-3 x 107 par-
asites/ml. The antileishmanial activity against pro-
mastigotes was determined using 96-well microplates 
(Sartorelli et al. 2007). Briefly, 1 x 106 promastigotes 
dissolved in methanol and diluted in M-199 medium 
(L. chagasi) or RPMI-1640 (L. amazonensis) medium 
were seeded with different extracts in the concentration 
range of 3.9 to 500 µg/ml. PMD was used as the standard 
drug. Plates were incubated at 24°C for 48 h and the vi-
ability of parasites was assayed colorimetrically by the 
mitochondrial oxidation of MTT (3-[4,5-dimethylthiaz-
ol-2-y1]-2,5diphenyl-tetrazolium bromide) (Tada et al. 
1986). The optical density was detected at 570 nm with 
a MULTISKAN MS microplate reader and correlated 
with the number of living promastigotes, which were 
adequately standardized for each plate. Control wells 
without any sample were established as 100% viable. 
Methanol was incubated with parasites at 0.5%/well and 
used as an internal control.
Antifungal activity assay - In order to evaluate the 
susceptibility of the FCZ-resistant yeast Candida kru-
sei (ATCC 6528) and the azole-susceptible Candida 
parapsilosis (ATCC 22019) to the extracts obtained, we 
developed an antimicrobial in vitro study. Candida spp. 
were maintained in RPMI 1640 medium (Sigma Chemi-
cals, USA) without sodium bicarbonate, supplemented 
with L-glutamine (Gibco, Invitrogen) and 2% glucose at 
pH 7.0. Two-fold dilutions of extract in concentrations 
ranging from 3.90 to 500 µg/ml were dissolved in RPMI 
1640 in 96-well microplates. Starting inoculum suspen-
sions were obtained by the spectrophotometric method 
of inoculum preparation adjusted to 1-5 x 106cfu/ml and 
then diluted in test medium to 1-5 x 105cfu/ml. A 100 µl 
yeast inoculum was added to each well and the plates 
were incubated for 24 h and 48 h at 35°C in a humid 
atmosphere. After agitation, plates were read spectro-
photometrically with an automatic plate reader (MULTI-
SKAN FLOW, Sweden) at 492 nm. Amb was used as the 
standard drug. The MTT method was also used to assay 
the viability of yeasts in order to evaluate the fungicidal 
activity of C. krusei (Hjertstedt et al. 1998). Methanol was 
incubated with yeasts at 0.5%/well and was used as an 
internal control.
Statistical analysis - Data represent the mean ± SD 
of duplicate samples from two independent assays. The 
EC50 values were calculated using sigmoid dose-response 
curves in Graph Pad Prism 3.0 software, and the 95% 
confidence intervals were included in parentheses.
RESULTS AND DISCUSSION
In our search for plants with antileishmanial and an-
tifungal activities, we tested methanolic crude extracts 
of native plants from the BAF. Our methodology was 
focused on plants traditionally used in Brazil and other 
countries for their anti-inflammatory and antimicrobial 
properties, as well as their specific antileishmanial and 
antifungal activities. Table I describes the 16 selected 
plants and their use in folk medicine. Many nonspecific 
symptoms such as fever, intestinal colic, and skin illness 
could be frequently described as microbial or parasitic in 
origin. Thus, many traditionally used plants may have an 
effect on a nonspecific target, thus contributing only as 
an anti-inflammatory. Laboratory in vitro testing models 
using cultured parasites, bacteria, or fungi, could be a 
useful and very important tool to confirm a specific ac-
tivity, as well as an ethnopharmacological use.
As show in Fig. 1, five crude extracts (P. amboinicus, 
A. cymbifera, P. barbatus, L. alba and H. bonariensis) 
killed 100% of L. chagasi promastigotes at their high-
est concentration (500 µg/ml). L. chagasi is the etiologic 
agent of Visceral Leishmaniasis in Brazil, a systemic 
disease that kills 100% of untreated patients (Rath et al. 
2003). From these five active extracts, four presented 
significant EC50 values in the concentration range of 45 
to 89 µg/ml (Table II), showing very promising possi-
bilities for future fractionation. These data suggest that 
very active compounds might be present in the crude 
extracts, and these may be a pool of a dozen indepen-
dent secondary metabolites. Further isolation of the ac-
tive compound could result in an individual prototype 
substance probably with a small EC50 value and better 
parasite selectivity. Based on 95% confidence intervals, 
P. barbatus and L. alba presented similar EC50 values 
against parasites, as did P. amboinicus and P. barbatus. 
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To our knowledge, this data corroborates, for the first 
time, the ethnopharmacological use of P. amboinicus 
for Leishmaniasis, having an EC50 value of 45.14 µg/ml. 
This species has been used in the treatment of skin ulcer-
ations caused by Leishmania spp. among the rural popu-
lation of the cocoa-producing coastal area in the state of 
Bahia, Brazil (Franca et al. 1996,) and has also been used 
to treat inflammatory disorders (Lorenzi & Matos 2002).
TABLE I
Plants, their traditional uses and activity described in the literature
Species (Family) Traditional use and activity described References
Albizia inundata Species of this genus are used in African Runyoro et al. (2006)
(Fabaceae - Mimosoideae) traditional Medicine to treat microbial infection
Aristolochia cymbifera Used in medicinal popular to treat fever, itching and eczema Lorenzi and Matos (2002)
(Aristolochiaceae)
Cipó-mil-homensa  
Baccharis trimera Used as anti-inflammatory and analgesic Gene et al. (1996)
(Asteraceae) Used against intestinal verminosis and malaria Lorenzi and Matos (2002)
carqueja a 
Bauhinia forficata Used in medicinal popular as anti-diabetic, against Duarte-Almeida et al. 
(Fabaceae-Cercideae) intestinal parasitosis and anti-inflammatory (2004),
pata-de-vacaa   Lorenzi and Matos (2002)
Calamintha adscendens Species of this genus are used as antimicrobial agent Panizzi et al. (1993)
(Lamiaceae)
Cymbopogon citratus Used in popular medicine to treat diarrhea, fever, cold Di Stasi et al. (2002)
(Poaceae) Antimicrobial properties Betoni et al. (2006)
capim-limãoa 
Eleutherine bulbosa Used as wound-healing agents on superficial Villegas et al. (1997)
(Iridaceae) and internal wounds (gastric ulcers) 
maruparia Used against intestinal verminosis and diarrhea Lorenzi and Matos (2002)
Herreria salsaparilha Used to treat inflammations, fever, skin infections De Carvalho (2001), 
(Agavaceae) and psoriases Lorenzi and Matos (2002)
Salsaparilhaa   
Hydrocotyle bonariensis Used to remove freckle and spots Lorenzi and Matos (2002)
(Apiaceae) Species of this genus is used to treat psoriases Natarajan and Paily (1973)
acariçobaa 
Justicia pectoralis var. stenophylla Used in folk medicine for respiratory tract diseases, Leal et al. (2000)
(Acanthaceae) lung infections and rheumatism Chariandy et al. (1999)
chambáa
Lippia alba Used against bacterial respiratory infections Caceres et al. (1991)
(Verbenaceae) Effective to relief intestinal and uterus colic Matos (1996)
erva-cidreira, salviaa 
Mentha X piperita Used as bactericidal, antifungal, anti-ulcer, anti-inflammatory McKay and Blumberg (2006)
(Lamiaceae)
hortelã-pimentaa
Plectranthus amboinicus Used in the treatment of cutaneous leishmaniasis due Franca et al. (1996),
(Lamiaceae) to Leishmania species Lorenzi and Matos (2002)
alfavaca-grossaa
Plectranthus barbatus Used in treatment of ailments of infectious and/or Matu and Van Staden (2003), 
(Lamiaceae) inflammatory nature Lukhoba et al. (2006)
boldo-brasileiroa
Plectranthus grandis Species of this genus are used to treat digestive, skin, infective Wellsow et al. (2006)
(Lamiaceae) and respiratory problems  
 Antimicrobial properties in this genus Lukhoba et al. (2006)
Plectranhus neochilus Species of this genus are used to treat digestive, skin,  Lukhoba et al. (2006)
(Lamiaceae) infective and respiratory problems
 Antimicrobial properties in this genus. Wellsow et al. (2006)
a: common name in Brazil.
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A. cymbifera, a member of the Aristolochiaceae fam-
ily, has been widely used to treat fevers, which are a very 
common and unspecific symptom (Lorenzi & Matos 
2002). In our assays, it has presented a high antileish-
manial activity with an EC50 of 89.17 µg/ml (Table II), 
and it has a fungicidal activity with an EC50 of 119.7 µg/
ml (Table III). To date, only antibacterial activity against 
Staphylococcus aureus and Pseudomonas aeruginosa by 
A. cymbifera has been described in the literature (De 
Barros Machado et al. 2005). Our results expand the sci-
entific knowledge by demonstrating promising activity 
against human pathogenic fungi and a protozoan para-
site. The traditional uses of P. barbatus in Kenya for the 
treatment of infectious and inflammatory diseases (Matu 
& van Staden 2003) have led our research to the find-
ing of an antileishmanial activity with a very promising 
EC50 value of 54.46 µg/ml against L. chagasi (Table II). 
Despite the cellular similarity among Leishmania spe-
cies, no activity was found against L. amazonensis, one 
of the etiologic agents of Cutaneous Leishmaniasis (CL) 
in Brazil. CL affects most poor communities all over the 
world. In some circumstances, the parasites migrate to 
mucosal areas, dramatically destroying the local tissue 
and contributing to a progressive and disfiguring in-
flammatory skin disease. 
From the 16 plant extracts studied against Leishmani-
asis, five presented activity against L. chagasi, and three 
distinct extracts showed an activity against L. amazon-
ensis. P. grandis showed a marked antileishmanial activ-
ity (EC50 of 188.0 µg/ml) (Fig. 2), corroborating the eth-
nophamacological use of this genus against skin illness, 
infection, and respiratory problems (Lukhoba et al. 2006). 
C. citratus has been traditionally used to treat diarrhea 
and fever and it led our research to the discovery of an an-
tiparasitic activity with an EC50 of 113.1 µg/ml (Table II). 
The medicinal use of B. trimera against the worldwide 
protozoan parasitic disease, malaria, as well as intestinal 
worms (Lorenzi & Matos 2002), resulted in our finding of 
an antileishmanial activity with an EC50 of 374.3 µg/ml. 
We also determined fungicidal activity against the FCZ-
resistant C. krusei with an EC50 of 133.1 µg/ml (Fig. 3).
The traditional use of L. alba to treat bacterial re-
spiratory infections (Caceres et al. 1991), as well as in-
testinal colic (Matos 1996), guided our research in the 
finding of new extracts against intracellular protozoan 
parasites and pathogenic yeasts. Our data confirmed the 
potent activity of L. alba, which was included among 
the four most active extracts against L. chagasi (EC50 of 
62.67 µg/ml). Our work reports for the first time a fungi-
cidal anti-Candida activity with an EC50 of 105.9 µg/ml. 
This data corroborates the anti-Candida activity of the 
Fig. 1: dose-response curve for the determination of the 50% Effective 
Concentration (µg/ml) of extracts of five plants against Leishmania 
(L.) chagasi promastigotes. Viability of parasites was determined at 
570 nm using MTT.
TABLE II
50% Effective Concentration (EC50) of extracts against Leishmania (L.) chagasi and Leishmania (L.) amazonensis promastigotes. 
Viability of parasites was determined at 570 nm using MTT. Pentamidine EC50 – 0.16 µg/ml (95% C.I. - 0.11-0.23 µg/ml)
 EC50 (µg/ml) 95% C.I. EC50 (µg/ml) 95% CI
Plant extract L. chagasi L. chagasi L. amazonensis L. amazonensis
Plectranthus amboinicus     45.14 44.33 - 45.96 >500 –
Aristolochia cymbifera     89.17 77.51 - 102.6 >500 –
Plectranthus barbatus     54.46 41.50 - 71.47 >500 –
Lippia alba     62.67 55.10 - 71.28 >500 –
Hydrocotyle bonariensis 235.0 148.7 - 371.5 302.5 236.1 - 387.5
Baccharis trimera >500 – 374.3 364.4 - 384.4
Cymbopogon citratus >500 – 113.1 81.19 - 157.7
Plectranthus grandis >500 – 188.0 187.0 - 188.9
Calamintha adscendens >500 – >500 –
Bauhinia forficata >500 – >500 –
Albizia inundata >500 – >500 –
Justicia pectoralis >500 – >500 –
Eleutherine bulbosa >500 – >500 –
Herreria salsaparilha >500 – >500 –
Mentha X piperita >500 – >500 –
Plectranthus neochilus >500 – >500 –
CI: confidence interval; MTT: 3-[4,5-dimethylthiazol-2-y1]-2,5diphenyl-tetrazolium bromide method.
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essential oil obtained from leaves of L. alba (Duarte et 
al. 2005). In the search for plants used to treat skin ill-
ness, we studied the methanolic extract of H. bonarien-
sis, which has been used in folk medicine to treat psoria-
sis, an inflammatory skin disorder (Natarajan & Paily 
1973). We found activity against L. amazonensis (EC50 
of 302.5 µg/ml), as well as L. chagasi promastigotes 
(EC50 of 235.0 µg/ml) in which 100% of parasites were 
killed at the highest concentration (500 µg/ml) (Fig. 1). 
Despite the elevated EC50 values when compared to oth-
er active plant extracts, H. bonariensis also presented a 
marked antifungal activity (EC50 of 31.63 µg/ml) (Table 
III) against the FCZ-resistant strain, Candida krusei. H. 
bonariensis has a fungicidal, rather than fungistatic ac-
tivity, as demonstrated by the lack the oxidative mito-
chondrial activity assayed with MTT (data not shown). 
Candidiasis are fungal infections that commonly affect 
the human skin. Recently, due to HIV and other immu-
nocompromised patients, candidiasis have been largely 
reported as a challenging invasive systemic infection. 
Many plants have been used in folk medicine to treat 
fungal infections (Lorenzi & Matos 2002). Besides the 
use of H. bonariensis in traditional medicine against skin 
illness, which could be frequently caused by pathogenic 
fungi, our data extend this knowledge to novel antipara-
sitic and antifungal activities.
Some other extracts showed a marked inhibition of 
the FCZ-resistant yeast, C. krusei. No antifungal activ-
ity of any tested extracts was found against the azole-
susceptible C. parapsilosis. Besides the investigation 
of the growth inhibition at 492 nm (Clancy & Nguyen 
1997), we extended our assays in order to demonstrate 
the potential killing effect of these plants, as most of the 
current drugs used in clinical therapy are fungistatic, 
rather than fungicidal, compounds. This characteristic 
limits the use of such agents by HIV-patients, because 
its prophylactic use should be limited to selected high-
risk patients to limit the risk of the emergence of azole-
resistant strains (Charlier et al. 2006).
Among the most effective tested extracts, P. neo-
chilus demonstrated, for the first time in the literature, 
a marked a marked EC50 value of 20.51 µg/ml, killing 
100% of yeast (C. krusei) at the highest concentration 
(Fig. 3). P. neochilus have also been traditionally used to 
treat skin and infective problems (Wellsow et al. 2006). 
Species of genus Albizia are used in African traditional 
medicine to treat microbial infection (Runyoro et al. 
2006). In addition, species of Calamintha are tradition-
ally used as antimicrobial agents in popular medicine 
(Panizzi et al. 1993). Despite the lack of antileishmanial 
activity detected for A. inundata and C. adscendens, our 
results show an antifungal activity against Candida al-
bicans and a fungicidal activity with an EC50 value of 
148.5 µg/ml at 492 nm and 196.3 µg/ml by MTT- 570 nm 
(data not shown) for A. Inundata. The anti-Candida ac-
tivity of A. inundata has been recently described and our 
results corroborate those found in literature for the ge-
nus Albizia (Runyoro et al. 2006).
Despite the broad traditional use of J. pectoralis var. 
s. stenophylla (Chariandy et al. 1999, Leal et al. 2000), 
H. salsaparilha (Rodrigues & De Carvalho 2001), Men-
Fig. 2: dose-response curve for the determination of the 50% Effective 
Concentration (µg/ml) of extracts of four plants against Leishmania 
(L.) amazonensis promastigotes. Viability of parasites was deter-
mined at 570 nm using MTT.
Fig. 3: activity of extracts of seven plant against Candida krusei at 
492 nm. 50% Effective Concentration (µg/ml) curves were determined 
using sigmoid dose-response at Graph Pad Prism 3.0 software.
TABLE III
50% Effective Concentration of extracts against Candida krusei. 
Growth inhibition of yeasts was determined at 492 nm
Plant Extract EC50 (µg/ml) 95% CI
Plectranthus amboinicus >500 –
Aristolochia cymbifera 49.66 40.99-60.16
Plectranthus barbatus >500 –
Lippia alba 165.20 136.90-199.40
Hydrocotyle bonariensis 137.70 94.16-201.30
Baccharis trimera 187.50 102.80-341.80
Cymbopogon citratus >500 –
Plectranthus grandis >500 –
Calamintha adscendens 112.20 98.57-127.80
Bauhinia forficata >500 –
Albizia inundata 49.66 40.00-60.16
Justicia pectoralis >500 –
Eleutherine bulbosa >500 –
Herreria salsaparilha >500 –
Mentha X piperita >500 –
Plectranthus neochilus 49.84 32.98-75.34
CI: confidence interval.
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tha X piperita (McKay & Blumberg 2006), and E. bul-
bosa (Villegas et al. 1997) in closely related diseases, 
such as skin illnesses, our assays demonstrated neither 
antileishmanial nor anti-Candida activities. Other patho-
genic species from the same genus could be susceptible 
to these same extracts. Continuous investigations must 
be done in order to find novel potent molecules against 
these important human diseases. Furthermore, Leish-
maniasis is a tropical neglected disease and investments 
for the search of novel drugs are urgent. The use of eth-
nopharmacological information could significantly slow 
the time and cost of the research, allowing the study of 
new drug prototypes for drug design studies.
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